Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHAA4549A + Oseltamivir in Severe Influenza A (CRANE)
NCT02293863Phase 2Completed
- Sponsor
- Genentech
- Start
- Jan 2015
- Primary completion
- May 2017
- Countries
- 25
01
Overview
A Phase 2 trial of vedolizumab in Influenza A (IAV), sponsored by Genentech. Started Jan 2015; status: completed.
02
Drugs
vedolizumab
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02293863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293863.